SEC Form 4 · accession 0001179110-17-004169
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael H. King
Officer — Chief Sales Officer
Period of report
Mar 3, 2017
Accepted (ET)
Mar 7, 2017 · 6:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $22.30 | Mar 3, 2017 | A | 95,115 | A | — | Mar 3, 2027 | Common Stock | 95,115 | 95,115 | D |
Explanation of responses
- F1The option will vest as to 25% of the shares on March 3, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter.